MedTrace Logo

An Observational Study on Renal Function in Kidney Transplant Participants on Immunosuppressive Therapy Containing Mycophenolate Mofetil

NCT01672957 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2016-10-11

Study results available
· View outcomes & findings →

Summary

This observational study will evaluate renal function in participants who underwent renal allograft transplantation and are started on combined immunosuppressive treatment containing mycophenolate mofetil (CellCept). Eligible participants will be followed for 12 months following transplantation.

Conditions

  • Kidney Transplantation

Interventions

DRUG

Mycophenolate Mofetil

Protocol does not specify any regimen for treatment. The choice of treatment will be made prior to enrollment by the treating physician.

DRUG

Immunosuppressive Therapy

Protocol does not specify any particular immunosuppressive drug and regimen for treatment. The choice of immunosuppressive therapy will be made prior to enrollment by the treating physician.

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01672957 on ClinicalTrials.gov